The pharma company announced the receipt of tentative approval from USFDA for its generic version of azelaic acid topical gel used for treating skin inflammation.
Glenmark Pharmaceuticals is currently trading at Rs. 753, up by Rs. 20.3 or 4.5% from its previous closing of Rs. 720.65 on the BSE.The pharma company announced receipt of tentative approval from USFDA for its generic version of azelaic acid topical gel used for treating skin inflammation.
The scrip opened at Rs. 730 and has touched a high and low of Rs. 745.5 and Rs. 725.6 respectively. So far 119898(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 20333.73 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1261.95 on 21-Aug-2015 and a 52 week low of Rs. 671.5 on 12-Feb-2016. Last one week high and low of the scrip stood at Rs. 726.6 and Rs. 671.5 respectively.
The promoters holding in the company stood at 46.47 % while Institutions and Non-Institutions held 42.5 % and 11.02 % respectively.
The stock is currently trading above its 200 DMA.
No comments:
Post a Comment